Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Sight Sciences Inc's Business Segments
Sight Sciences Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q1 FY2026
Reportable Segments
2
Largest Segment
Surgical Glaucoma
Total Revenue
$ 19
Regions Reported
-
Revenue Share by Reportable Segment - Q1 FY2026
- Surgical Glaucoma96.7%
- Dry Eye7.1%
Revenue by Reportable Segment - Q1 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Surgical Glaucoma | $ 18 | 96.7% |
| Dry Eye | $ 1 | 7.1% |
Description of Sight Sciences Inc
Sight Sciences Inc is a medical technology company that is revolutionizing the field of ophthalmology with its innovative products and solutions. The company is focused on developing and commercializing devices that improve the surgical treatment of glaucoma and other eye diseases.
Sight Sciences was founded in 2011 and is headquartered in Menlo Park, California. It has a team of experienced engineers, scientists, and ophthalmologists who work together to develop cutting-edge technologies that address the unmet needs of patients and healthcare professionals in the field of ophthalmology.
One of the flagship products of Sight Sciences is the OMNI Surgical System, which is designed to be a comprehensive solution for the treatment of glaucoma. The OMNI system combines multiple technologies, including microcatheters, cannulas, and other surgical instruments, to create a minimally invasive platform that allows surgeons to perform a wide range of procedures with precision and efficiency. The system enables surgeons to lower intraocular pressure, which is a key factor in managing glaucoma, by facilitating the outflow of aqueous humor from the eye.
Another key product offered by Sight Sciences is the TearCare System, which is designed to address the issue of evaporative dry eye syndrome. The TearCare system uses wearable, disposable eyelid devices to deliver controlled, localized heat therapy to the meibomian glands in the eyelids. This innovative approach helps to restore natural tear film and relieve the symptoms associated with evaporative dry eye syndrome.
In addition to its innovative products, Sight Sciences also provides comprehensive training and support to healthcare professionals using its technology. The company works closely with ophthalmologists to train them in the use of its devices and ensure that they are able to obtain optimal outcomes for their patients.
Sight Sciences has gained recognition and acclaim for its groundbreaking technologies. Its products have received regulatory approvals from various authorities, including the US Food and Drug Administration (FDA) and the European CE Mark. The company has also been granted numerous patents for its technologies, highlighting its commitment to innovation and intellectual property.
Overall, Sight Sciences Inc is a pioneering company in the field of ophthalmology, dedicated to improving the lives of patients suffering from eye diseases. With its innovative products, comprehensive training, and commitment to excellence, Sight Sciences is poised to continue making significant contributions to the medical community and revolutionize the treatment of eye diseases.
Sight Sciences was founded in 2011 and is headquartered in Menlo Park, California. It has a team of experienced engineers, scientists, and ophthalmologists who work together to develop cutting-edge technologies that address the unmet needs of patients and healthcare professionals in the field of ophthalmology.
One of the flagship products of Sight Sciences is the OMNI Surgical System, which is designed to be a comprehensive solution for the treatment of glaucoma. The OMNI system combines multiple technologies, including microcatheters, cannulas, and other surgical instruments, to create a minimally invasive platform that allows surgeons to perform a wide range of procedures with precision and efficiency. The system enables surgeons to lower intraocular pressure, which is a key factor in managing glaucoma, by facilitating the outflow of aqueous humor from the eye.
Another key product offered by Sight Sciences is the TearCare System, which is designed to address the issue of evaporative dry eye syndrome. The TearCare system uses wearable, disposable eyelid devices to deliver controlled, localized heat therapy to the meibomian glands in the eyelids. This innovative approach helps to restore natural tear film and relieve the symptoms associated with evaporative dry eye syndrome.
In addition to its innovative products, Sight Sciences also provides comprehensive training and support to healthcare professionals using its technology. The company works closely with ophthalmologists to train them in the use of its devices and ensure that they are able to obtain optimal outcomes for their patients.
Sight Sciences has gained recognition and acclaim for its groundbreaking technologies. Its products have received regulatory approvals from various authorities, including the US Food and Drug Administration (FDA) and the European CE Mark. The company has also been granted numerous patents for its technologies, highlighting its commitment to innovation and intellectual property.
Overall, Sight Sciences Inc is a pioneering company in the field of ophthalmology, dedicated to improving the lives of patients suffering from eye diseases. With its innovative products, comprehensive training, and commitment to excellence, Sight Sciences is poised to continue making significant contributions to the medical community and revolutionize the treatment of eye diseases.
Sight Sciences Inc. is a medical technology company focused primarily on developing innovative solutions for the treatment of chronic eye conditions, particularly glaucoma and dry eye disease. The company aims to transform the standard of care by integrating advanced technology into minimally invasive procedures, thereby improving patient outcomes and enhancing the performance of healthcare providers. Below are extensive descriptions of the segments, products, and services offered by Sight Sciences Inc.
Segments
1. Glaucoma:
- This segment focuses on developing minimally invasive surgical (MIS) devices designed for the treatment of glaucoma, a condition characterized by increased intraocular pressure that can lead to optic nerve damage and irreversible vision loss.
- The company’s innovative approach allows for effective and efficient drainage of excess aqueous humor, helping to lower intraocular pressure without the need for traditional surgical techniques.
2. Dry Eye Disease:
- The dry eye segment concentrates on addressing the various causes and symptoms of dry eye disease, a common condition that arises when the eyes do not produce enough tears or the tears evaporate too quickly.
- Products in this segment aim to restore balance to the tear film and alleviate discomfort for patients suffering from this chronic condition.
Products
1. iStent Infinite:
- This is a micro-invasive glaucoma surgery (MIGS) device designed to lower intraocular pressure in patients with mild to moderate glaucoma.
- The iStent Infinite allows for the creation of a permanent opening in the eye’s drainage system while preserving the natural anatomy of the eye, which can facilitate fluid outflow and reduce pressure effectively.
2. iPrv® (iPulse):
- The iPrv device represents a new class of treatment for dry eye disease that uses a novel pulsatile technology.
- It is designed to enhance the natural production of tears through stimulation of the meibomian glands, addressing one of the underlying causes of dry eye symptoms.
3. Surround® System:
- This is a device designed for managing glaucoma that incorporates both surgical and therapeutic features.
- The Surround System promotes effective outflow of aqueous humor to manage intraocular pressure while allowing for ergonomic handling and ease of use during procedures.
4. TearCare®:
- This system is targeted at patients suffering from meibomian gland dysfunction (MGD), the leading cause of evaporative dry eye disease.
- The TearCare system gently heats the eyelids to facilitate the expression of obstructed meibomian glands, restoring the lipid layer of the tear film and improving ocular comfort.
Services
1. Clinical Support and Education:
- Sight Sciences Inc. offers extensive educational resources and clinical support to healthcare professionals. This includes training on the use of their technology, surgical techniques, and best practices for patient care.
- The aim is to ensure that healthcare providers are well-equipped to offer the newest solutions effectively and safely.
2. Research and Development (R&D):
- The companys R&D division is dedicated to continuous innovation in eye care technology. This segment conducts clinical trials, gathers real-world evidence, and engages in partnerships with academic institutions and researchers to advance the field of ophthalmology.
- Sight Sciences places a strong emphasis on understanding patient needs and developing products that meet those demands.
3. Patient Engagement Programs:
- The company provides resources designed to improve patient education about eye health and the management of chronic conditions like glaucoma and dry eye.
- Engagement programs may include informational materials, online resources, and support networks to assist patients in understanding their conditions and available treatments.
Overall, Sight Sciences Inc. stands out for its commitment to enhancing patient care through innovative surgical and therapeutic interventions in ophthalmology. The company seeks not just to develop cutting-edge products but also to facilitate education and support for both healthcare providers and patients, thereby fostering a holistic approach to eye health.
Segments
1. Glaucoma:
- This segment focuses on developing minimally invasive surgical (MIS) devices designed for the treatment of glaucoma, a condition characterized by increased intraocular pressure that can lead to optic nerve damage and irreversible vision loss.
- The company’s innovative approach allows for effective and efficient drainage of excess aqueous humor, helping to lower intraocular pressure without the need for traditional surgical techniques.
2. Dry Eye Disease:
- The dry eye segment concentrates on addressing the various causes and symptoms of dry eye disease, a common condition that arises when the eyes do not produce enough tears or the tears evaporate too quickly.
- Products in this segment aim to restore balance to the tear film and alleviate discomfort for patients suffering from this chronic condition.
Products
1. iStent Infinite:
- This is a micro-invasive glaucoma surgery (MIGS) device designed to lower intraocular pressure in patients with mild to moderate glaucoma.
- The iStent Infinite allows for the creation of a permanent opening in the eye’s drainage system while preserving the natural anatomy of the eye, which can facilitate fluid outflow and reduce pressure effectively.
2. iPrv® (iPulse):
- The iPrv device represents a new class of treatment for dry eye disease that uses a novel pulsatile technology.
- It is designed to enhance the natural production of tears through stimulation of the meibomian glands, addressing one of the underlying causes of dry eye symptoms.
3. Surround® System:
- This is a device designed for managing glaucoma that incorporates both surgical and therapeutic features.
- The Surround System promotes effective outflow of aqueous humor to manage intraocular pressure while allowing for ergonomic handling and ease of use during procedures.
4. TearCare®:
- This system is targeted at patients suffering from meibomian gland dysfunction (MGD), the leading cause of evaporative dry eye disease.
- The TearCare system gently heats the eyelids to facilitate the expression of obstructed meibomian glands, restoring the lipid layer of the tear film and improving ocular comfort.
Services
1. Clinical Support and Education:
- Sight Sciences Inc. offers extensive educational resources and clinical support to healthcare professionals. This includes training on the use of their technology, surgical techniques, and best practices for patient care.
- The aim is to ensure that healthcare providers are well-equipped to offer the newest solutions effectively and safely.
2. Research and Development (R&D):
- The companys R&D division is dedicated to continuous innovation in eye care technology. This segment conducts clinical trials, gathers real-world evidence, and engages in partnerships with academic institutions and researchers to advance the field of ophthalmology.
- Sight Sciences places a strong emphasis on understanding patient needs and developing products that meet those demands.
3. Patient Engagement Programs:
- The company provides resources designed to improve patient education about eye health and the management of chronic conditions like glaucoma and dry eye.
- Engagement programs may include informational materials, online resources, and support networks to assist patients in understanding their conditions and available treatments.
Overall, Sight Sciences Inc. stands out for its commitment to enhancing patient care through innovative surgical and therapeutic interventions in ophthalmology. The company seeks not just to develop cutting-edge products but also to facilitate education and support for both healthcare providers and patients, thereby fostering a holistic approach to eye health.